A Phase III Randomized, Double-Blind Placebo Controlled Study of Armodafinil (Nuvigil®) To Reduce Cancer-Related Fatigue in Patients With High Grade Glioma

This randomized phase III trial studies armodafinil to see how well it works in reducing cancer-related fatigue in patients with high grade glioma. Armodafinil may help relieve fatigue in patients with high grade glioma.

 

For more information contact us at DFCC_Clinical_Research@providence.org or call (818) 748-4793

Site located at Roy and Patricia Disney Family Cancer Center at Providence Saint Joseph Medical Center.

Location: 181 S. Buena Vista St. , Burbank, CA 91505

Participate in a Clinical Trial

Learn More